Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

LV Chao, HUANG Huimei, CHANG Wanlin, LIU Runhui. Screening of active compounds of pro-angiogenic in Shexiang Baoxin pill[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(5): 344-347,351. doi: 10.3969/j.issn.1006-0111.2014.05.007
Citation: LV Chao, HUANG Huimei, CHANG Wanlin, LIU Runhui. Screening of active compounds of pro-angiogenic in Shexiang Baoxin pill[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(5): 344-347,351. doi: 10.3969/j.issn.1006-0111.2014.05.007

Screening of active compounds of pro-angiogenic in Shexiang Baoxin pill

doi: 10.3969/j.issn.1006-0111.2014.05.007
  • Received Date: 2014-04-03
  • Rev Recd Date: 2014-06-27
  • Objective To screen and identify the main pro-angiogenic compounds of Shexiang Baoxin pill (SBP) presenting in the plasma. Methods The pro-angiogenic effects of SBP and its compounds absorbed into blood were measured by the cell proliferation and cell migration assays by xCELLigence. And the cell tube formation and rat aortic ring models were established to evaluate their pro-angiogenic effect. Results SBP(10-4~10-2 μg/ml), ginsenoside Rg3(1~10 μmol/L) and ginsenoside Rh2(1~10 μmol/L)significantly stimulated human umbilical vein endothelial cells (HUVECs) proliferation, migration and tube-like structures formation at different concentrations (P<0.05). In addition, compared to the control group, only the high concentration group of SBP (10-2 μg/ml), Rg3(10 μmol/L) and Rh2(10 μmol/L)could induce endothelial cell sprouting from the aortic ring(P<0.05). Conclusion SBP, ginsenosideRg3 and Rh2 exhibited significantly pro-angiogenic effect in vitro.
  • [1] Cao Y. Angiogenesis:What can it offer for future medicine[J]. Exp Cell Res,2010,316(8):1304-1308.
    [2] 陈静. 麝香保心丸血管新生作用为世界瞩目—剑桥大学加大对麝香保心丸研究力度[J]. 中国社区医师,2010,(12):16.
    [3] 杨雪英, 郑晓晖, 王彦方. 麝香保心丸对缺血性心脏病患者内皮功能及心功能的影响[J]. 中成药,2007,29(2):171-173.
    [4] 储敏, 宋国秀. 麝香保心丸对狗及大鼠实验性心肌梗塞的保护作用[J]. 中成药,1996,18(5):30-31.
    [5] 李天奇, 李勇, 范维琥. 麝香保心丸和辛伐他汀对兔股动脉粥样硬化斑块稳定性的影响[J]. 中华老年心脑血管病杂志,2006,8(5):296-299.
    [6] 汪姗姗, 李勇. 麝香保心丸对实验性心肌梗塞大鼠心脏的促血管生成作用[J]. 中成药,2002,24(6):446-449.
    [7] 李勇. 麝香保心丸促进治疗性血管新生的实验研究[J]. 中国社区医师,2006,22(9):19-20.
    [8] O'Rourke M, Ward C, Worthington J, et al. Evaluation of the antiangiogenic potential of AQ4N[J]. Clin Cancer Res,2008,14(5):1502-1509.
    [9] 曾群英,王礼春,高修仁,等. 急性冠脉综合征早期辅助应用麝香保心丸治疗的作用及安全性临床研究[J]. 中西医结合心脑血管病杂志,2003,1(4):221-223.
    [10] Atienza JM, Yu N, Kirstein SL, et al. Dynamic and label-free cell-based assays using the real-time cell electronic sensing system[J]. Assay Drug Dev Technol,2006,4(5):597-607.
    [11] Solly K, Wang X, Xu X, et al. Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays[J]. Assay Drug Dev Technol,2004,2(4):363-372.
    [12] Shen K, Ji L, Gong C, et al. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways[J]. Biochem Pharmacol, 2012,84(6):784-792.
    [13] 耿怀成, 陈龙邦, 王靖华, 等. 人参皂苷Rg3抗肿瘤新生血管形成的实验研究[J]. 医学研究生学报,2002,15(6):493-495.
    [14] 杨成明, 刘伟, 赵燕颖, 等. 人参单体皂苷Rh2抑制缺氧条件下人视网膜血管内皮细胞增殖及整合素αvβ3 表达的研究[J]. 中国老年学杂志, 2008,28(6):557-559.
    [15] Kim YS, Jin SH, Lee YH, et al. Differential expression of protein kinase C subtypes during ginsenoside Rh2-induced apoptosis in SK-N-BE (2) and C6Bu-1 cells[J]. Arch Pharm Res,2000,23(5):518-524.
    [16] Nicosia RF, McCormick JF, Bielunas J. The formation of endothelial webs and channels in plasma clot culture[J]. Scan Eelect Microl, 1983,793-799.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2750) PDF downloads(138) Cited by()

Related
Proportional views

Screening of active compounds of pro-angiogenic in Shexiang Baoxin pill

doi: 10.3969/j.issn.1006-0111.2014.05.007

Abstract: Objective To screen and identify the main pro-angiogenic compounds of Shexiang Baoxin pill (SBP) presenting in the plasma. Methods The pro-angiogenic effects of SBP and its compounds absorbed into blood were measured by the cell proliferation and cell migration assays by xCELLigence. And the cell tube formation and rat aortic ring models were established to evaluate their pro-angiogenic effect. Results SBP(10-4~10-2 μg/ml), ginsenoside Rg3(1~10 μmol/L) and ginsenoside Rh2(1~10 μmol/L)significantly stimulated human umbilical vein endothelial cells (HUVECs) proliferation, migration and tube-like structures formation at different concentrations (P<0.05). In addition, compared to the control group, only the high concentration group of SBP (10-2 μg/ml), Rg3(10 μmol/L) and Rh2(10 μmol/L)could induce endothelial cell sprouting from the aortic ring(P<0.05). Conclusion SBP, ginsenosideRg3 and Rh2 exhibited significantly pro-angiogenic effect in vitro.

LV Chao, HUANG Huimei, CHANG Wanlin, LIU Runhui. Screening of active compounds of pro-angiogenic in Shexiang Baoxin pill[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(5): 344-347,351. doi: 10.3969/j.issn.1006-0111.2014.05.007
Citation: LV Chao, HUANG Huimei, CHANG Wanlin, LIU Runhui. Screening of active compounds of pro-angiogenic in Shexiang Baoxin pill[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(5): 344-347,351. doi: 10.3969/j.issn.1006-0111.2014.05.007
Reference (16)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return